Arcadia Biosciences Q1 revenue falls 8%, swings to loss

Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc.

RKDA

0.00


Overview

  • Wellness products maker's Q1 revenue fell 8% yr/yr, driven by prior-year reserve release

  • Co reported net loss compared to profit a year ago, reflecting warrant inducement loss and absence of prior-year gains

  • Zola coconut water unit volumes rose 18% yr/yr, and benefitted by price increase


Outlook

  • Company expects to launch a new product at major customers this fall

  • Arcadia remains focused on growing its Zola coconut water brand


Result Drivers

  • ZOLA VOLUME AND PRICE - Zola coconut water unit volumes rose 18% yr/yr and benefited from a price increase, boosting product sales

  • REVENUE RESERVE IMPACT - Revenue decline was mainly due to a $193,000 revenue reserve release in Q1 2025 that did not recur

  • ABSENCE OF PRIOR-YEAR GAINS - Operating expenses rose due to the absence of a $750,000 gain on patent portfolio sale and $1.0 mln gain from contingent consideration liability in Q1 2025


Company press release: ID:nGNXbrlsZj


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Revenue

$1.10 mln

Q1 EPS

-$2.11

Q1 Net Income

-$4.39 mln

Q1 Operating Expenses

$1.88 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.